Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, Ontario, CanadaDr. Peter Lin began his studies in the Faculty of Science and Engineering at the University of Toronto in Toronto, Ontario. Midway through, he moved to the Faculty of Medicine, where he completed his studies and became involved in research. Over the years, it became apparent to him that there was a wide chasm between research and clinical practice, and he moved into clinical practice in primary care and eventually into teaching in order to help bridge this gap. He served as the medical director at the Health & Wellness Centre, University of Toronto Scarborough, for 7 years.
Currently, Dr. Peter Lin is the Director of Primary Care Initiatives at the Canadian Heart Research Centre. He is also a contributing author to the Canadian Diabetes Guidelines 2013 and 2018 on the vascular protection section. He is also Associate Editor for the Elsevier WebPortal - PracticeUpdate Primary Care. He lectures and speaks internationally on a variety of topics. Dr. Lin has worked with KDIGO in order to help improve care for CKD patients. He has also been tracking and providing information on COVID-19 to the public since the beginning of the pandemic. Dr. Lin received a teaching award from the College of Family Physicians in 2011.
Disclosures
Dr. Lin has consulted with the following companies on Continuing Medical Education programs:Astrazeneca, Boeringher Ingelheim, Bayer, Eli Lilly, Amgen, Janssen, Merck, Pfizer, Sanofi, Abbott, HLS Therapeutics Inc.
No clinical trials. No patents.
Recent Contributions to PracticeUpdate:
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular Disease: Implications for Statin Therapy From the Multi-Ethnic Study of Atherosclerosis
- Herpes Zoster: Diagnostic, Therapeutic, and Preventive Approaches
- AAFP Votes to Ban Energy Drink Sales to Kids
- Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus Pneumoniae Serotypes in US Adults Aged ≥ 50 Years With Community-Acquired Pneumonia
- Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels-Balancing Benefits and Risks: Evidence From a Large Community-Based Study
- Increased Risk of Exacerbation and Hospitalization in Subjects With an Overlap Phenotype: COPD-Asthma
- Air Travel: Effects of Sleep Deprivation and Jet Lag
- Efficacy and Safety of Cognitive Enhancers for Patients With Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
- Severe Hypoglycaemia and Cardiovascular Disease: Systematic Review and Meta-Analysis With Bias Analysis